The molecular and clinical verification of therapeutic resistance via the p38 MAPK–Hsp27 axis in lung cancer

Treatment failure followed by relapse and metastasis in patients with non-small cell lung cancer is often the result of acquired resistance to cisplatin-based chemotherapy. A cancer stem cell (CSC)-mediated anti-apoptotic phenomenon is responsible for the development of drug resistance. The underlyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chia-Lin, Chen, Su-Feng, Wu, Min-Zu, Jao, Shu-Wen, Lin, Yaoh-Shiang, Yang, Chin-Yuh, Lee, Tsai-Yu, Wen, Lian-Wu, Lan, Guo-Lun, Nieh, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924714/
https://www.ncbi.nlm.nih.gov/pubmed/26872057
http://dx.doi.org/10.18632/oncotarget.7306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924714/
https://www.ncbi.nlm.nih.gov/pubmed/26872057
http://dx.doi.org/10.18632/oncotarget.7306

Ejemplares similares